| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e85005cdc3959b93caba0553ac10fa48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_336e6d51954be634522682dfefbc95ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c9539c6ee3c61eecef5889d195a4a90 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-172 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2006-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35fed33b96e642e9d33768b4af50ba26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b47e6a757c7922e9775928f369e1c142
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9d0168fba018c70540b70ef4337b49f |
| publicationDate |
2007-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007111239-A1 |
| titleOfInvention |
Methods of using il-21 |
| abstract |
An allelic variation in the IL-21 receptor can result in reduced IFN-γ production in individuals and can require administration of different doses of IL-21 to achieve therapeutic effects seen individuals that do not have the allelic variant. Based on the genotype of a patient's IL-21 receptor allele, methods of predicting therapeutic response to treatment with IL-21 are disclosed. Also disclosed are methods of selecting a therapeutic regimen for use of IL-21 in patients with variant IL-21 receptor alleles. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009150080-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8315816-B2 |
| priorityDate |
2005-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |